We launched COVID Vaccine Facts, a new website with scientific and evidence-based information related to the COVID-19 vaccine development process. More details below, plus a look at the benefits of biotech crops. (663 words, 3 minutes, 18 seconds)
BIO challenges “Most Favored Nation” drug pricing…
It’s another busy day in Washington. In the meantime, we have details on our legal challenge to the Trump administration’s drug pricing plan, as well as a look at a new report on the health impacts of climate change and how sustainable biobased…
BIO's new agenda to promote justice through equity
BIO launched an important new agenda to eliminate racial disparities in the industry and health care delivery. We’ve got the details, in around 670 words, just under 4 minutes.
Starting the last week of July with a look at a recent report on human genome editing from the WHO's Expert Committee, as well as what we know about how to combat vaccine hesitancy. (762 words, 3 minutes, 48 seconds)
ICYMI: African swine fever is making a comeback in Germany—this time in farm pigs. We explain how we could end this disease, as well as recap what BIO’s Dr. Michelle said during a Washington Post event about health equity. (770 words, 3 minutes, 51 seconds)
Lots of newness today: the new COVAX Marketplace, BIO’s new VP for Agriculture and Environment, and more news from Washington. (888 words, 4 minutes, 26 seconds)
Today, we have a quick recap of yesterday’s Senate hearing on the federal COVID-19 response, plus a look at a must-read long-read on how the tide is turning on GMOs and why it matters. (842 words, 4 minutes, 12 seconds)
Today, we look at a recent report that has both good and bad news on cancer deaths in the U.S., as well as how gene editing can make biryani ingredients more sustainable and resilient. (772 words, 3 minutes, 51 seconds)
We start a new week bearing bad news: COVID cases are rising across the U.S., and extreme climate events are increasing around the world. Fortunately, biotech can deliver solutions to both challenges—but we have some work to do to get them where they need to go. (766 words, 3 minutes, 49 seconds)
Closing the week with a promising bipartisan bill that would establish an out-of-pocket cap for Medicare Part D beneficiaries, as well as USDA’s nominee to oversee marketing and regulatory programs. Plus—we have an inspiring new I am BIO video to start your weekend right. (851 words, 4 minutes, 31 seconds)
Ahead of German Chancellor Angela Merkel’s visit to Washington, BIO sent a letter to her government about how we can collaborate on global vaccine access—we have the scoop. Plus, LanzaTech has a new partnership to produce clothing from carbon. (1,000 words, 5 minutes)
Last week, the U.S. Trade Representative met with Mexican government officials to discuss Mexico’s policy toward biotech crops—we have the readout, plus insights from yesterday’s Senate Judiciary hearing on competition policy for prescription drugs. (807 words, 4 minutes, 2 seconds)
Today, we have a deep dive into a new report on the regulatory framework for gene editing of agricultural animals, as well as three concrete things your company can do right now to improve diversity, equity, and inclusion in the biotech industry. (819 words, 4 minutes, 5 seconds)
